107 related articles for article (PubMed ID: 22002702)
1. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
Schuhmacher C; Gretschel S; Lordick F; Reichardt P; Hohenberger W; Eisenberger CF; Haag C; Mauer ME; Hasan B; Welch J; Ott K; Hoelscher A; Schneider PM; Bechstein W; Wilke H; Lutz MP; Nordlinger B; Van Cutsem E; Siewert JR; Schlag PM
J Clin Oncol; 2010 Dec; 28(35):5210-8. PubMed ID: 21060024
[TBL] [Abstract][Full Text] [Related]
2. Esophagogastric Cancer: The Current Role of Radiation Therapy.
Tchelebi LT; Goodman KA
Hematol Oncol Clin North Am; 2024 Jun; 38(3):569-583. PubMed ID: 38485552
[TBL] [Abstract][Full Text] [Related]
3. Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.
Kleo K; Jovanovic VM; Arndold A; Lehmann A; Lammert H; Berg E; Harloff H; Treese C; Hummel M; Daum S
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1049-1061. PubMed ID: 35246724
[TBL] [Abstract][Full Text] [Related]
4. Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers.
Bain GH; Petty RD
Oncologist; 2010; 15(3):270-84. PubMed ID: 20203174
[TBL] [Abstract][Full Text] [Related]
5. Treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy.
Yan Y; Feng X; Li C; Lerut T; Li H
Chin Med J (Engl); 2022 Sep; 135(18):2143-2156. PubMed ID: 36525602
[TBL] [Abstract][Full Text] [Related]
6. Customizing Therapy for Esophageal Cancer: CROSS vs. FLOT.
Tasnim S; Sudarshan M
Ann Surg Oncol; 2024 Jan; 31(1):21-22. PubMed ID: 37833462
[No Abstract] [Full Text] [Related]
7. Treatment of gastric adenocarcinoma: A rapidly evolving landscape.
Taieb J; Bennouna J; Penault-Llorca F; Basile D; Samalin E; Zaanan A
Eur J Cancer; 2023 Dec; 195():113370. PubMed ID: 37948843
[TBL] [Abstract][Full Text] [Related]
8. Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma.
Clements HA; Underwood TJ; Petty RD
Br J Cancer; 2024 Jan; 130(1):9-18. PubMed ID: 37898721
[TBL] [Abstract][Full Text] [Related]
9. Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up.
Stelmach R; Apostolidis L; Kahle S; Sisic L; Nienhüser H; Weber TF; Jäger D; Haag GM
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14785-14796. PubMed ID: 37589924
[TBL] [Abstract][Full Text] [Related]
10. Expression of concern: "Patient-derived organoids from locally advanced gastric adenocarcinomas can predict resistance to neoadjuvant chemotherapy" [J Gastrointest Surg. 2023 Apr;27(4):666-76].
J Gastrointest Surg; 2024 Jun; 28(6):1008. PubMed ID: 38839209
[No Abstract] [Full Text] [Related]
11. A case report of SMARCA4-deficient undifferentiated tumor in the esophago-gastric junction.
Deng L; Li B
Asian J Surg; 2023 Nov; 46(11):5330-5331. PubMed ID: 37537060
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Neoadjuvant Chemotherapy Does not Increase Postoperative Complications Compared with Upfront Surgery in Gastric Adenocarcinoma: A Population-Based, Nationwide Study in Finland.
Emilia P; Helminen O; Kauppila JH;
Ann Surg Oncol; 2024 Apr; 31(4):2711-2712. PubMed ID: 38206506
[No Abstract] [Full Text] [Related]
13. Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial.
Yang P; Tian Y; Tan B; Ding P; Guo H; Liu Y; Zhang Z; Li Y; Zhao Q
J Gastrointest Oncol; 2021 Oct; 12(5):2052-2060. PubMed ID: 34790373
[TBL] [Abstract][Full Text] [Related]
14. [Palliative surgery in visceral medicine. Exemplified by colorectal and gastric cancer].
Ptok H; Gastinger I; Wolff S; Bruns C; Lippert H
Chirurg; 2016 Mar; 87(3):216-24. PubMed ID: 26857001
[TBL] [Abstract][Full Text] [Related]
15. Positron Emission Tomography (PET) in Oncology.
Gallamini A; Zwarthoed C; Borra A
Cancers (Basel); 2014 Sep; 6(4):1821-89. PubMed ID: 25268160
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of recurrence patterns in esophageal carcinoma after surgery alone and surgery after neoadjuvant chemoradiotherapy: a secondary analysis of the CROSS study].
Hautmann MG; Kölbl O
Strahlenther Onkol; 2014 Jul; 190(7):696-8. PubMed ID: 25061651
[No Abstract] [Full Text] [Related]
17. [Palliative treatment of advanced gastric cancer from surgical point of view].
Gastinger I; Windisch J; Meyer F; Ptok H; Steinert R; Otto R; Bruns C; Lippert H
Chirurg; 2015 Jun; 86(6):570-6. PubMed ID: 24994589
[TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.
Van de Wiele C; Kruse V; Smeets P; Sathekge M; Maes A
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):290-301. PubMed ID: 23151913
[TBL] [Abstract][Full Text] [Related]
19. [Gastric cancer and adenocarcinoma of the esophagogastric junction: principles of neoadjuvant therapy].
Lordick F; Ott K; Sendler A
Chirurg; 2011 Nov; 82(11):968-73. PubMed ID: 22002702
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
